CROMSOURCE provides accurate and real-time safety management of global drug studies in all phases of clinical research. Our expert Pharmacovigilance team is in constant and direct communication with physicians, CRAs, regulatory authorities, and the client to ensure full control at every stage of the project. The CROMSOURCE medical teams are also experienced, certified users of EudraVigilance.
CROMSOURCE is experienced in addressing the disparate safety reporting requirements in different EU countries and the US. Our experts are strategically based in different time zones across Europe and North America to ensure uninterrupted services.
Our medical monitors are available 24/7 in all time zones in order to address any safety issues as they arise.
Safety reports are managed proactively so that the sponsor and investigator teams are fully invested in any safety decisions made or expedited reports submitted. Experienced CROMSOURCE medical staff will interface with regulatory authorities (including the FDA) and sponsors to ensure that any safety issues that arise are managed efficiently and pragmatically.